English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/134231
COMPARTIR / IMPACTO:
Estadísticas
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Título

Therapeutic targeting of the myeloma stem cell

AutorVicente-Dueñas, Carolina ; Sánchez García, Isidro
Fecha de publicación2013
EditorInforma Healthcare
CitaciónLeukemia and Lymphoma 21(2): 37-47 (2013)
ResumenMultiple myeloma (MM) is characterized by the abnormal expansion of neoplastic plasma cells, and the nature of its cell-of-origin is still controversial. MM remains an incurable disease for the vast majority of patients. The existence of MM stem cells (MMSCs) is considered to be one of the major causes of MM drug resistance, leading to disease relapse. This emphasizes the importance and urgency of developing approaches to target MMSCs. However, the MMSC phenotype remains controversial and very little is known about its molecular characteristics, which makes it difficult to target the MMSC therapeutically.
URIhttp://hdl.handle.net/10261/134231
Identificadoresissn: 1042-8194
e-issn: 1029-2403
Aparece en las colecciones: (IBMCC) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
accesoRestringido.pdf15,38 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.